WhyPeptides

ClinicalTrials.gov research-record information

ClinicalTrials.gov research records

ClinicalTrials.gov research-record snapshot for Fort Worth, TX

Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 8 results; after an exact city/state check of listed facilities, 8 records were retained for Fort Worth, Texas. It is not a clinic, enrollment, or local-availability directory.

Snapshot methodology and exact-location matching

City/state source filter
Fort Worth, Texas
Exact-location inclusion rule
A listed facility city and state must match Fort Worth, Texas.

Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.

Fixed query terms

  • semaglutide
  • tirzepatide
  • cagrilintide
  • retatrutide
  • tesamorelin
  • sermorelin
  • ipamorelin
  • bpc-157
  • thymosin alpha 1
  • pt-141

Included study statuses

  • RECRUITING
  • NOT_YET_RECRUITING
  • ACTIVE_NOT_RECRUITING
  • ENROLLING_BY_INVITATION

How to read this snapshot

Research-record limits

All retained records

Study-level status mix

The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.

RECRUITING
3 records
NOT_YET_RECRUITING
0 records
ACTIVE_NOT_RECRUITING
5 records
ENROLLING_BY_INVITATION
0 records

Records in this snapshot

Retained ClinicalTrials.gov NCT records

The retrieved source snapshot contains 8 exact-location records and 5 listed facilities. All 8 retained records are shown below.

NCT06439277

Registry title: A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Valley Institute of Research - Fort WorthFort Worth, Texas 76164

NCT07165028

Registry title: A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • GI Alliance - Fort WorthFort Worth, Texas 76104

NCT06383390

Registry title: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Diabetes and Thyroid Center of Ft. WorthFort Worth, Texas 76132
  • Valley Institute of Research - Fort WorthFort Worth, Texas 76164

NCT06864026

Registry title: A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Fort WorthFort Worth, Texas 76109

NCT07357415

Registry title: A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Cedar Health Research - Fort WorthFort Worth, Texas 76132

NCT07232719

Registry title: A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Cedar Health Research - Fort WorthFort Worth, Texas 76132

NCT06260722

Registry title: Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Valley Institute of Research - Fort WorthFort Worth, Texas 76164

NCT05556512

Registry title: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Diabetes and Thyroid Center of Ft. WorthFort Worth, Texas 76132
  • Valley Institute of Research - Fort WorthFort Worth, Texas 76164

Source retrieval and snapshot limits

Source-query results versus exact-location records

At retrieval, the fixed ClinicalTrials.gov source query returned 8 results. After an exact city/state check of listed facilities, 8 records were retained for Fort Worth, Texas, across 5 listed facilities. All 8 retained records are shown on this page.

Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Source-query results
8
Exact-location records retained
8
Listed facilities retained
5
Records shown
8 of 8
Fixed ClinicalTrials.gov source query (JSON) Broader live ClinicalTrials.gov search (no status filter)

Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.

Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.